The U.S. Food and Drug Administration (FDA) has granted accelerated approval to a new oral drug combination for treating a…
Browsing: FDAApproval
The FDA has approved a groundbreaking gene therapy for a rare genetic skin disorder called recessive dystrophic epidermolysis bullosa (RDEB).…
A new treatment for generalized myasthenia gravis (gMG), a chronic autoimmune disease that causes severe muscle weakness and fatigue, has…
The FDA has granted approval for a groundbreaking cell-based gene therapy aimed at treating recessive dystrophic epidermolysis bullosa (RDEB), a…
The FDA has approved Dupixent for the treatment of chronic spontaneous urticaria (CSU) in adults and children aged 12 and…
A new treatment has been approved by the FDA for adults suffering from a serious kidney disorder known as primary…
The U.S. Food and Drug Administration (FDA) has approved a groundbreaking new drug for the preventive treatment of hemophilia. This…
The U.S. Food and Drug Administration (FDA) has taken a significant step forward in pediatric neurology by approving the first…
The approval of the first treatment for pediatric Myasthenia Gravis marks a groundbreaking achievement in the medical field. This rare…
The approval of the first-ever treatment for pediatric myasthenia gravis marks a significant breakthrough in the field of neurology and…